# New York Times Co: financial statements, quarterly NYT · NYSE · CIK 71691 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/nyt.md) · [Financials](/companies/nyt/financials.md) · [Filings](/companies/nyt/filings.md) · [Insiders](/companies/nyt/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nyt/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [598](/filings/0000071691-24-000160.md) | [676 d](/filings/0000071691-26-000011.md) | [594](/filings/0000071691-25-000100.md) | [625](/filings/0000071691-25-000119.md) | [640](/filings/0000071691-25-000126.md) | [727 d](/filings/0000071691-26-000011.md) | [636](/filings/0000071691-26-000025.md) | [686](/filings/0000071691-26-000034.md) | [701](/filings/0000071691-25-000126.md) | [802 d](/filings/0000071691-26-000011.md) | [712](/filings/0000071691-26-000025.md) | [762](/filings/0000071691-26-000034.md) | | Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Research and development | $m | [57.4](/filings/0000071691-24-000160.md) | [58.3 d](/filings/0000071691-26-000011.md) | [63.2](/filings/0000071691-25-000100.md) | [62.2](/filings/0000071691-25-000119.md) | [61.0](/filings/0000071691-25-000126.md) | [61.8 d](/filings/0000071691-26-000011.md) | [66.5](/filings/0000071691-26-000025.md) | [63.9](/filings/0000071691-26-000034.md) | [67.0](/filings/0000071691-25-000126.md) | [66.9 d](/filings/0000071691-26-000011.md) | [70.2](/filings/0000071691-26-000025.md) | [70.4](/filings/0000071691-26-000034.md) | | Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating income | $m | [63.6](/filings/0000071691-24-000160.md) | [129 d](/filings/0000071691-26-000011.md) | [48.3](/filings/0000071691-25-000100.md) | [79.4](/filings/0000071691-25-000119.md) | [76.7](/filings/0000071691-25-000126.md) | [147 d](/filings/0000071691-26-000011.md) | [58.6](/filings/0000071691-26-000025.md) | [107](/filings/0000071691-26-000034.md) | [105](/filings/0000071691-25-000126.md) | [162 d](/filings/0000071691-26-000011.md) | [90.6](/filings/0000071691-26-000025.md) | [118](/filings/0000071691-26-000034.md) | | Income tax | $m | [16.4](/filings/0000071691-24-000160.md) | [29.6 d](/filings/0000071691-26-000011.md) | [15.2](/filings/0000071691-25-000100.md) | [21.5](/filings/0000071691-25-000119.md) | [20.9](/filings/0000071691-25-000126.md) | [31.9 d](/filings/0000071691-26-000011.md) | [14.4](/filings/0000071691-26-000025.md) | [28.7](/filings/0000071691-26-000034.md) | [26.4](/filings/0000071691-25-000126.md) | [37.8 d](/filings/0000071691-26-000011.md) | [10.4](/filings/0000071691-26-000025.md) | [31.8](/filings/0000071691-26-000034.md) | | Net income | $m | [53.6](/filings/0000071691-24-000160.md) | [110 d](/filings/0000071691-26-000011.md) | [40.4](/filings/0000071691-25-000100.md) | [65.5](/filings/0000071691-25-000119.md) | [64.1](/filings/0000071691-25-000126.md) | [124 d](/filings/0000071691-26-000011.md) | [49.6](/filings/0000071691-26-000025.md) | [82.9](/filings/0000071691-26-000034.md) | [81.6](/filings/0000071691-25-000126.md) | [130 d](/filings/0000071691-26-000011.md) | [87.9](/filings/0000071691-26-000025.md) | [93.4](/filings/0000071691-26-000034.md) | | Diluted EPS | $ per share | [0.32](/filings/0000071691-24-000160.md) | not reported | [0.24](/filings/0000071691-25-000100.md) | [0.40](/filings/0000071691-25-000119.md) | [0.39](/filings/0000071691-25-000126.md) | not reported | [0.30](/filings/0000071691-26-000025.md) | [0.50](/filings/0000071691-26-000034.md) | [0.50](/filings/0000071691-25-000126.md) | not reported | [0.54](/filings/0000071691-26-000025.md) | [0.57](/filings/0000071691-26-000034.md) | | Basic EPS | $ per share | [0.33](/filings/0000071691-24-000160.md) | not reported | [0.25](/filings/0000071691-25-000100.md) | [0.40](/filings/0000071691-25-000119.md) | [0.39](/filings/0000071691-25-000126.md) | not reported | [0.30](/filings/0000071691-26-000025.md) | [0.51](/filings/0000071691-26-000034.md) | [0.50](/filings/0000071691-25-000126.md) | not reported | [0.54](/filings/0000071691-26-000025.md) | [0.58](/filings/0000071691-26-000034.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: not reported - Gross profit: not reported - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: not reported - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [236](/filings/0000071691-24-000160.md) | [289](/filings/0000071691-25-000047.md) | [207](/filings/0000071691-25-000100.md) | [223](/filings/0000071691-25-000119.md) | [205](/filings/0000071691-25-000126.md) | [199](/filings/0000071691-26-000011.md) | [183](/filings/0000071691-26-000025.md) | [198](/filings/0000071691-26-000034.md) | [249](/filings/0000071691-25-000126.md) | [255](/filings/0000071691-26-000034.md) | [187](/filings/0000071691-26-000025.md) | [233](/filings/0000071691-26-000034.md) | | Current assets | $m | [658](/filings/0000071691-23-000034.md) | [782](/filings/0000071691-25-000047.md) | [681](/filings/0000071691-24-000105.md) | [716](/filings/0000071691-24-000132.md) | [795](/filings/0000071691-24-000160.md) | [936](/filings/0000071691-26-000011.md) | [802](/filings/0000071691-25-000100.md) | [855](/filings/0000071691-25-000119.md) | [938](/filings/0000071691-25-000126.md) | [1,028](/filings/0000071691-26-000034.md) | [927](/filings/0000071691-26-000025.md) | [1,023](/filings/0000071691-26-000034.md) | | Total assets | $m | [2,547](/filings/0000071691-23-000034.md) | [2,715](/filings/0000071691-25-000047.md) | [2,623](/filings/0000071691-24-000105.md) | [2,673](/filings/0000071691-24-000132.md) | [2,762](/filings/0000071691-24-000160.md) | [2,841](/filings/0000071691-26-000011.md) | [2,735](/filings/0000071691-25-000100.md) | [2,805](/filings/0000071691-25-000119.md) | [2,887](/filings/0000071691-25-000126.md) | [2,997](/filings/0000071691-26-000034.md) | [2,859](/filings/0000071691-26-000025.md) | [2,985](/filings/0000071691-26-000034.md) | | Current liabilities | $m | [554](/filings/0000071691-23-000034.md) | [612](/filings/0000071691-25-000047.md) | [545](/filings/0000071691-24-000105.md) | [543](/filings/0000071691-24-000132.md) | [590](/filings/0000071691-24-000160.md) | [614](/filings/0000071691-26-000011.md) | [555](/filings/0000071691-25-000100.md) | [578](/filings/0000071691-25-000119.md) | [615](/filings/0000071691-25-000126.md) | [667](/filings/0000071691-26-000034.md) | [578](/filings/0000071691-26-000025.md) | [648](/filings/0000071691-26-000034.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,653](/filings/0000071691-23-000034.md) | [1,763](/filings/0000071691-25-000047.md) | [1,748](/filings/0000071691-24-000105.md) | [1,805](/filings/0000071691-24-000132.md) | [1,852](/filings/0000071691-24-000160.md) | [1,927](/filings/0000071691-26-000011.md) | [1,885](/filings/0000071691-25-000100.md) | [1,936](/filings/0000071691-25-000119.md) | [1,980](/filings/0000071691-25-000126.md) | [2,041](/filings/0000071691-26-000034.md) | [2,001](/filings/0000071691-26-000025.md) | [2,048](/filings/0000071691-26-000034.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: not reported - Current portion of debt: not reported - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [104 d](/filings/0000071691-24-000160.md) | [137 d](/filings/0000071691-26-000011.md) | [53.1](/filings/0000071691-25-000100.md) | [80.2 d](/filings/0000071691-25-000119.md) | [126 d](/filings/0000071691-25-000126.md) | [152 d](/filings/0000071691-26-000011.md) | [99.1](/filings/0000071691-26-000025.md) | [114 d](/filings/0000071691-26-000034.md) | [208 d](/filings/0000071691-25-000126.md) | [164 d](/filings/0000071691-26-000011.md) | [92.2](/filings/0000071691-26-000025.md) | [194 d](/filings/0000071691-26-000034.md) | | Capital expenditure | $m | [5.7 d](/filings/0000071691-24-000160.md) | [6.1 d](/filings/0000071691-26-000011.md) | [6.4](/filings/0000071691-25-000100.md) | [7.6 d](/filings/0000071691-25-000119.md) | [7.1 d](/filings/0000071691-25-000126.md) | [8.1 d](/filings/0000071691-26-000011.md) | [9.2](/filings/0000071691-26-000025.md) | [10.3 d](/filings/0000071691-26-000034.md) | [7.9 d](/filings/0000071691-25-000126.md) | [6.5 d](/filings/0000071691-26-000011.md) | [10.7](/filings/0000071691-26-000025.md) | [10.1 d](/filings/0000071691-26-000034.md) | | Dividends paid | $m | [18.2 d](/filings/0000071691-24-000160.md) | [18.1 d](/filings/0000071691-26-000011.md) | [18.6](/filings/0000071691-25-000100.md) | [21.4 d](/filings/0000071691-25-000119.md) | [21.5 d](/filings/0000071691-25-000126.md) | [21.4 d](/filings/0000071691-26-000011.md) | [22.1](/filings/0000071691-26-000025.md) | [29.6 d](/filings/0000071691-26-000034.md) | [29.4 d](/filings/0000071691-25-000126.md) | [29.3 d](/filings/0000071691-26-000011.md) | [30.4](/filings/0000071691-26-000025.md) | [37.2 d](/filings/0000071691-26-000034.md) | | Share repurchases | $m | [0.0 d](/filings/0000071691-24-000160.md) | [1.0 d](/filings/0000071691-26-000011.md) | [32.5](/filings/0000071691-25-000100.md) | [9.5 d](/filings/0000071691-25-000119.md) | [18.3 d](/filings/0000071691-25-000126.md) | [24.7 d](/filings/0000071691-26-000011.md) | [59.0](/filings/0000071691-26-000025.md) | [23.6 d](/filings/0000071691-26-000034.md) | [27.3 d](/filings/0000071691-25-000126.md) | [55.5 d](/filings/0000071691-26-000011.md) | [56.3](/filings/0000071691-26-000025.md) | [35.4 d](/filings/0000071691-26-000034.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [166](/filings/0000071691-23-000034.md) | [165](/filings/0000071691-24-000105.md) | [165](/filings/0000071691-24-000132.md) | [165](/filings/0000071691-24-000160.md) | [166](/filings/0000071691-25-000100.md) | [166](/filings/0000071691-25-000119.md) | [166](/filings/0000071691-25-000126.md) | [165](/filings/0000071691-26-000025.md) | [164](/filings/0000071691-26-000034.md) | [164](/filings/0000071691-25-000126.md) | [164](/filings/0000071691-26-000025.md) | [163](/filings/0000071691-26-000034.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.